1
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Comparing Schedules of Daily Peritoneal Dialysis

, , , , , & show all
Pages 311-324 | Published online: 07 Jul 2009
 

Abstract

Starting November 1973, peritoneal dialyses have been performed 7 days a week on a group of 18 patients, 11 of whom still on the program. A short daily dialysis technique at a dialysate flow of 2.5 L/hour was used. This group of patients has undergone 9,724 dialyses, 86.8% of which at home.

A group of 4 patients had to be switched to hemodialysis. During the last 16 months a total of 5,670 short daily dialyses have been performed, 97.4% of which at home.

Another group of 6 patients has undergone Continuous Ambulatory Peritoneal Dialysis (CAPD) for 24 hours daily with 10-liter dialysate containing 3-4.25 g/100 ml dextrose. A total of 967 dialyses have been performed. Peritonitis occurred in 7 instances, and 2 patients had to be switched to hemodialysis.

In summary, daily dialysis with either schedule reveals itself suitable for home program and requires a much smaller financial effort from the community. The data presented indicate that CAPD constitutes the most physiological approach to the problem of waste removal and fulfills the old dream of dialysists, i.e., to remove the toxics at the time they are produced. CAPD still deserves the efforts of specialists in the field in minimizing the risk of peritonitis and/or protein losses.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.